{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T01:10:20Z","timestamp":1723943420201},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2002,10,29]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            Salt-sensitive hypertension represents a major cause of left ventricular (LV) dysfunction. We therefore explored the potential effects of the selective endothelin-A (ETA) receptor antagonist darusentan on the development of hypertension, LV hypertrophy (LVH), and dysfunction in a genetic rat model of salt-sensitive hypertension.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Animals from the salt-sensitive Sabra rat strain (SBH\/y) and the salt-resistant strain (SBN\/y) were treated with either normal diet (SBH\/y and SBN\/y) or with deoxycorticosterone-acetate (DOCA) and salt (SBN\/y-DOCA and SBH\/y-DOCA). Additional groups were treated with 50 mg \u00b7 kg\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7 d\n            <jats:sup>\u22121<\/jats:sup>\n            of darusentan (SBH\/y-DOCA-DA and SBN\/y-DOCA-DA). Systolic blood pressure and LV weight increased in response to DOCA only in the SBH\/y strain (+75 mm Hg and +30%;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). LV end-diastolic pressure increased and \u2212dP\/dtmax decreased in SBH\/y-DOCA compared with SBH\/y (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). This was paralleled by a 5-fold upregulation of LV mRNA expression of atrial natriuretic factor (ANF) and a significant reduction of sarcoplasmic reticulum (SR) Ca\n            <jats:sup>2+<\/jats:sup>\n            -reuptake and the SR Ca\n            <jats:sup>2+<\/jats:sup>\n            -ATPase to phospholamban protein ratio (\u221230%). Whereas treatment with darusentan in SBH\/y-DOCA-DA reduced the SBP increase by 50%, LVH elevation of ANF mRNA and LV dysfunction were completely prevented (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05); this was associated with a normalization of SR Ca\n            <jats:sup>2+<\/jats:sup>\n            -reuptake and SR Ca\n            <jats:sup>2+<\/jats:sup>\n            -ATPase to phospholamban ratio by darusentan (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05). A moderate elevation of interstitial fibrosis in SBH\/y-DOCA (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) remained unaffected by darusentan treatment.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusion\u2014<\/jats:italic>\n            <\/jats:bold>\n            In the Sabra model of salt-sensitive hypertension, ETA-receptor blockade demonstrated striking effects on the prevention of LVH and LV dysfunction beyond its considerable antihypertensive effect.\n          <\/jats:p>","DOI":"10.1161\/01.cir.0000038703.78148.54","type":"journal-article","created":{"date-parts":[[2002,10,28]],"date-time":"2002-10-28T22:22:10Z","timestamp":1035843730000},"page":"2305-2308","update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Endothelin-A Receptor Blockade Prevents Left Ventricular Hypertrophy and Dysfunction in Salt-Sensitive Experimental Hypertension"],"prefix":"10.1161","volume":"106","author":[{"given":"Lars","family":"Rothermund","sequence":"first","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Vetter","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"Dieterich","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kossmehl","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u0308zlem","family":"Go\u0308gebakan","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chana","family":"Yagil","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Yagil","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[{"name":"From the Institut fu\u0308r Klinische Pharmakologie (L.R., M.D., P.K., O\u0308.G., R.K.) und Toxikologie (R.V.), Medizinische Klinik IV Nephrologie (L.R., R.K.), Benjamin Franklin Hospital, Freie Universita\u0308t Berlin, Berlin, Germany; and Laboratory for Molecular Medicine and Department of Nephrology and Hypertension (C.Y., Y.Y.), Faculty of Health Sciences, Ben-Gurion University, Barzilai Medical Center Campus, Ashkelon, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.4.876"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.2.263"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199610000-00004"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02933-3"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.13.1582"},{"key":"e_1_3_3_6_2","first-page":"H264","volume":"275","year":"1998","journal-title":"Am J Physiol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00932.x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature00786"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.66.2.2137041"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.272.5.H2416"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715120-00087"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.75.3.8062417"},{"key":"e_1_3_3_13_2","first-page":"H779","volume":"276","year":"1999","journal-title":"Am J Physiol"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.1.215"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1996.271.2.F451"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441802"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000038703.78148.54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:31:45Z","timestamp":1715020305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000038703.78148.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,29]]},"references-count":16,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2002,10,29]]}},"alternative-id":["10.1161\/01.CIR.0000038703.78148.54"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000038703.78148.54","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,29]]},"assertion":[{"value":"2002-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}